Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
panobinostat (farydak) (1 trial)
Leukemia (Phase 2)
Leukemia-Lymphoma, Adult T-Cell (Phase 2)
Leukemia, T-Cell (Phase 2)
Lymphoma (Phase 2)
Lymphoma, T-Cell (Phase 2)
Lymphoma, T-Cell, Cutaneous (Phase 2)
Trials (1 total)
Trial APIs (1 total)